Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Expansion of Advanced Tissues Sciences/Smith & Nephew joint venture planned

Jan. 26, 1998

Laminin-related polypeptides from the University of Minnesota

Jan. 26, 1998

Lexacalcitol: a vitamin D analogue with increased potency

Jan. 23, 1998

Connetics to develop clobetasol mousse for dermatoses

Jan. 16, 1998

Genzyme General discontinues U.S. development of Sepracoat

Jan. 15, 1998

New class of glucocorticoids with an improved pharmacological profile

Jan. 15, 1998

IMPDH inhibitor VX-497 advances to clinical trials

Jan. 14, 1998

OrthoLogic makes equity investment in Chrysalis; acquires rights to new peptide

Jan. 13, 1998

Cellegy acquires Anogesic

Jan. 13, 1998

ADCON-L submitted to regulatory authorities

Jan. 9, 1998

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...